Publicaciones en colaboración con investigadores/as de Servicio de Salud del Principado de Asturias (SESPA) (25)

2024

  1. Diurnal cortisol throughout pregnancy and its association with maternal depressive symptoms and birth outcomes

    Psychoneuroendocrinology, Vol. 161

2023

  1. Psychological impact of the COVID-19 pandemic and lockdown in a Spanish sample with anxiety disorder: sex differences

    Actas espanolas de psiquiatria, Vol. 51, Núm. 2, pp. 65-75

2022

  1. Early Impact of the COVID-19 Outbreak on Sleep in a Large Spanish Sample

    Behavioral Sleep Medicine, Vol. 20, Núm. 3, pp. 100-115

  2. Is it possible to stage schizophrenia? A systematic review

    Translational Psychiatry, Vol. 12, Núm. 1

2021

  1. Are older adults also at higher psychological risk from COVID-19?

    Aging and Mental Health, Vol. 25, Núm. 7, pp. 1297-1304

  2. Factors associated with alcohol and tobacco consumption as a coping strategy to deal with the coronavirus disease (COVID-19) pandemic and lockdown in Spain

    Addictive Behaviors, Vol. 121

  3. Impact of the coronavirus outbreak on mental health in the different Spanish regions

    Actas espanolas de psiquiatria, Vol. 49, Núm. 2, pp. 64-70

  4. Spanish Validation of the MAP-SR: Two Heads Better Than One for the Assessment of Negative Symptoms of Schizophrenia

    Psicothema, Vol. 33, Núm. 3, pp. 473-480

2020

  1. COVID-19 lockdown in people with severe mental disorders in Spain: Do they have a specific psychological reaction compared with other mental disorders and healthy controls?

    Schizophrenia Research, Vol. 223, pp. 192-198

  2. Cognitive impairment and C-reactive protein in clinically stable schizophrenia outpatients: a focus on sex differences

    Scientific Reports, Vol. 10, Núm. 1

  3. Sex-dependent grades of haematopoietic modulation in patients with major depressive episodes are associated with suicide attempts

    European Neuropsychopharmacology, Vol. 40, pp. 17-30

  4. Tratamientos psicológicos de tercera generación

    Manual de trastornos adictivos (J. Belarmino Bobes, M. Casas y M. Gutiérrez), pp. 323-333

2019

  1. Can interleukin-2 and interleukin-1β be specific biomarkers of negative symptoms in schizophrenia?

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 1, pp. 9-16

  2. Could structural changes in the retinal layers be a new biomarker of mental disorders? A systematic review and thematic synthesis

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 2, pp. 116-129

  3. Detección de la intoxicación por cannabinoides sintéticos en Urgencias: cuando las pruebas toxicológicas rutinarias no bastan

    Adicciones: Revista de socidrogalcohol, Vol. 31, Núm. 2, pp. 174-175

  4. Early versus late stage schizophrenia. What markers make the difference?

    World Journal of Biological Psychiatry, Vol. 20, Núm. 2, pp. 159-165

  5. Is the alteration in emotional recognition a specific risk factor of suicide attempt?

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 3, pp. 196-198

  6. Predicting real-world functioning in outpatients with schizophrenia: Role of inflammation and psychopathology

    Psychiatry Research, Vol. 280

  7. Social cognition in bipolar disorder: the role of sociodemographic, clinical, and neurocognitive variables in emotional intelligence

    Acta Psychiatrica Scandinavica, Vol. 139, Núm. 4, pp. 369-380

2018

  1. Association between genetic variation in the myo-inositol monophosphatase 2 (IMPA2) gene and age at onset of bipolar disorder

    Journal of Affective Disorders, Vol. 232, pp. 229-236